Biomarkers in breast cancer : molecular diagnostics for predicting and monitoring therapeutic effect /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[2006]
|
| Series: | Cancer drug discovery and development.
|
| Subjects: |
Table of Contents:
- Guidelines for the design of clinical studies for the development and validation of therapeutically relevant biomarkers and biomarker-based classification systems
- Analytical aspects of biomarker immunoassays in cancer research
- Tissue microarrays : state-of-the-art, pitfalls, and promises
- Gene expression profiling with DNA microarrays : revolutionary tools to help diagnosis, prognosis, treatment guidance, and drug discovery
- Assays for gene amplification : state-of-the-art, pitfalls and promises
- Cell kinetics
- Urokinase-type plasminogen activator and PAI-1 : validated prognostic factors for breast cancer
- Predictive value of c-erb-B2 for endocrine therapy and chemotherapy in breast cancer
- erb-B2 as a therapeutic target
- The epidermal growth factor receptor pathway as a selective molecular-targeted treatment in human breast cancer
- p53 as a prognostic and predictive indicator
- Predictive biomarkers in body fluids
- Occult metastatic cells in breast cancer patients : state-of-the-art, pitfalls, and promises
- Circulating HER2/neu : clinical utility
- Circulating vascular endothelial growth factor : methods, prognostic significance, and potential application for antiangiogenic therapy
- Detection of early tumor dissemination in patients with breast cancer
- New technologies/new markers/new challenges